Sort
326,823 grants matching “clinical trial”
Longitudinal validation of cerebral small vessel disease biomarkers in diverse community-based older adults without dementia
$2,472,997Konstantinos Arfanakis · Rush University Medical Center · UF1 · FY2021 · NS
Thalassemia Clinic Research Network
$2,472,937Sonja M McKinlay · New England Research Institutes, Inc. · U01 · FY2006 · HL
Foamy Viral Gene Therapy for X-linked Severe Combined Immune Deficiency
$2,472,869David J Rawlings · Seattle Children'S Hospital · P01 · FY2014 · AI
Mechanisms of Energy Balance and Cancer Prevention
$2,472,758Fred Hutchinson Cancer Research Center · U54 · FY2005 · CA
Treatment of Preserved Systolic Function with an Aldosterone Antagonist
$2,472,282Rebecca Li · New England Research Institutes, Inc. · N01 · FY2013 · HL
NSTN National Clinical Coordinating Center
$2,472,191Joseph Paul Broderick · University Of Cincinnati · U01 · FY2013 · NS
Clinical Trial Unit for HIV Prevention and Microbicide Research
$2,472,041Kenneth H Mayer · Fenway Community Health Center · U01 · FY2009 · AI
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
$2,471,790Jennifer Lapek · Scripps Institution Of Oceanography · N01 · FY2023 · AI
Fred Hutchinson Cancer Center Lung SPORE
$2,471,718A. McGarry Houghton · Fred Hutchinson Cancer Center · P50 · FY2025 · CA
CLINICAL AND LABORATORY STUDIES OF MALIGNANT LYMPHOMAS
$2,471,663Stanford University · P01 · FY2004 · CA
Mayo Clinic Breast Cancer SPORE
$2,471,635Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2018 · CA
Mechanisms and treatment of retinal degeneration in animal models and humans
$2,471,232Paul Sieving · National Institute On Deafness And Other Communication Disorders · Z01 · FY2008 · DC
Gene Therapy for Leber Congenital Amaurosis
$2,471,068University Of Florida · U10 · FY2003 · EY
Established Status Epilepticus Treatment Trial (ESETT)
$2,470,918Jaideep Kapur · University Of Virginia · U01 · FY2018 · NS
Establishing the science behind Alzheimer's recruitment registries: opportunities for increasing diversity and accelerating enrollment into trials
$2,470,609Jessica Brooke Langbaum · Banner Health · R01 · FY2022 · AG
Targeting epithelial cells to treat pulmonary fibrosis
$2,470,358Dean Sheppard · University Of California, San Francisco · P01 · FY2015 · HL
OPTIMIZATION OF HIGH DOSE CONFORMAL THERAPY
$2,470,329University Of Michigan At Ann Arbor · P01 · FY2004 · CA
Coordinating Center for the Undiagnosed Diseases Network
$2,470,320Rachel L Badovinac · Harvard Medical School · U01 · FY2015 · HG
Personalized Medicine in Nevada COBRE
$2,470,275Martin R Schiller · University Of Nevada Las Vegas · P20 · FY2018 · GM
Aging, Cognition, and Hearing Evaluation in Elders (ACHIEVE) Randomized Trial
$2,469,860Frank R Lin · Johns Hopkins University · R01 · FY2019 · AG
Biology of Long-Term Mechanical Circulatory Support
$2,469,779Yoshifumi Naka · Columbia University Health Sciences · P50 · FY2008 · HL
South-seq: DNA sequencing for newborn nurseries in the South
$2,469,743Gregory Michael Cooper · Hudson-Alpha Institute For Biotechnology · U01 · FY2021 · HG
Optical Technologies and Molecular Imaging for Cervical Neoplasia
$2,469,576Michele Follen · Texas Tech University Health Scis Center · P01 · FY2012 · CA
Center for Genomically Engineered Organs
$2,469,443George M Church · Harvard Medical School · RM1 · FY2015 · HG
Comparing Treatment Approaches to Promote Inpatient Rehabilitation Effectiveness for Traumatic Brain Injury (CARE 4 TBI)
$2,469,383Jennifer A Bogner · Ohio State University · UH3 · FY2025 · NS